| Issue |
Title |
File |
| Vol 13, No 2 (2011) |
Sovremennye aspekty i nekotoryediskussionnye voprosy primeneniyatrastuzumaba |
|
|
Frolova M.A., Stenina M.B.
|
| Vol 12, No 1 (2010) |
Sovremennye aspektyprofilaktiki neytropeniipri khimioterapii solidnykh opukholey |
|
|
Abramov M.E., Zhukova L.G.
|
| Vol 2, No 1 (2000) |
Sovremennye dannye o vozmozhnostyakh khirurgicheskogo lecheniya bol'nykh rakom podzheludochnoy zhelezy i periampulyarnoy zony |
|
|
Patyutko Y.I., Kotel'nikov A.G., Kosyrev V.Y., Mikhaylov M.M., Sokolova I.N., Akhmetov M.S., Sagaydak I.V.
|
| Vol 7, No 3 (2005) |
Sovremennye metodiki laparoskopicheskoy diagnostiki opukholevykh zabolevaniy organov bryushnoy polosti |
|
|
Poddubnyy B.K., Gubin A.N., Sholokhov V.N., Vakurova E.S., Cherkes L.V., Vakulovskaya E.G., Blyumenberg A.G.
|
| Vol 12, No 1 (2010) |
Sovremennye napravleniya lecheniyaneyroendokrinnykh opukholey |
|
|
Gorbunova V.A., Orel N.F., Kuz'minov A.E.
|
| Vol 13, No 1 (2011) |
Sovremennye podkhody k lecheniyu bol'nykh stromal'nymi opukholyami zheludochno-kishechnogo trakta |
|
|
Vashakmadze L.A., Khomyakov V.M., Kolobaev I.V.
|
| Vol 4, No 1 (2002) |
Sovremennye podkhody k lecheniyu limfogranulematoza (limfomy Khodzhkina) |
|
|
Demina E.A.
|
| Vol 2, No 4 (2000) |
Sovremennye podkhody k lecheniyu metastazov v kosti |
|
|
Kondrat'eva A.P.
|
| Vol 10, No 2 (2008) |
Sovremennye podkhody k lecheniyui profilaktike tromboticheskikh oslozhneniy v onkologii |
|
|
Ptushkin V.V.
|
| Vol 3, No 3 (2001) |
Sovremennye podkhody k terapii bol'nykh rasprostranennym rakom yaichnikov: rol' gemzara |
|
|
Kharitonova T.V.
|
| Vol 12, No 1 (2010) |
Sovremennye podkhodyk lecheniyu anemii u bol'nykhs onkogematologicheskimizabolevaniyami |
|
|
Bessmel'tsev S.S., Romanenko N.A., Abdulkadyrov K.M.
|
| Vol 6, No 1 (2004) |
Sovremennye predstavleniya o lechenii pervichnykh bol'nykh limfomoy Khodzhkina |
|
|
Demina E.A.
|
| Vol 10, No 1 (2008) |
Sovremennye printsipy organizatsii nutritivnoy podderzhki onkologicheskikh bol'nykh |
|
|
Grozdova T.Y., Danilov O.I.
|
| Vol 6, No 3 (2004) |
Sovremennye programmy lecheniya pervichnykh bol'nykh limfomoy Khodzhkina |
|
|
Demina E.A.
|
| Vol 5, No 2 (2003) |
Sovremennye standarty lecheniya raka yaichnikov |
|
|
Kharitonova T.V.
|
| Vol 8, No 2 (2006) |
Sovremennye vozmozhnosti korrektsii khronicheskoy anemii u onkologicheskikh bol'nykh |
|
|
Zhukov N.V., Kurmukov I.A.
|
| Vol 5, No 3 (2003) |
Sovremennye vozmozhnosti lecheniya gormonorefrakternogo raka predstatel'noy zhelezy |
|
|
Matveev B.P., Bukharkin B.V.
|
| Vol 8, No 2 (2006) |
Sovremennye vozmozhnosti lecheniya kolorektal'nogo raka |
|
|
Barsukov Y.A., Knysh V.I.
|
| Vol 7, No 3 (2005) |
Sovremennye vozmozhnosti lekarstvennoy terapii operabel'nogo raka molochnoy zhelezy (po materialam St. Gallen, 2005) |
|
|
Letyagin V.P., Vysotskaya I.V.
|
| Vol 2, No 4 (2000) |
Sovremennye vozmozhnosti profilakticheskoy immunoterapi i rekombinantnym interferonom al'fa-2' u bol'nykh melanomoy kozhi s vysokim riskom metastazirovaniya |
|
|
Demidov L.V., Kharkevich G.Y.
|
| Vol 1, No 2 (1999) |
Sovremennye vozmozhnostii perspektivy khimioterapii nemelkokletochnogo raka legkogo |
|
|
Perevodchikova N.I.
|
| Vol 17, No 3 (2015) |
Sovremennyy podkhod k lecheniyu nerezektabel'noy i metastaticheskoy melanomy. Rol' ingibitorov BRAF i MEK |
|
|
Stroyakovskiy D.L.
|
| Vol 12, No 3 (2010) |
Spornye aspekty HER2-diagnostiki |
|
|
Imyanitov E.N.
|
| Vol 13, No 1 (2011) |
Spraysel odobren v Rossii dlya vzroslykh patsientovs vpervye vyyavlennym khronicheskim mieloidnym leykozom (KhML) |
|
|
- -.
|
| Vol 22, No 4 (2020) |
Squamous cell breast cancer: description of a rare clinical case |
(Rus)
|
|
Zikiryakhodjaev A.D., Khakimova S.G., Rasskazova E.A., Saribekian E.K., Omarova D.F., Surkova V.S., Khakimova G.G.
|
| Vol 25, No 2 (2023) |
Squamous cell carcinoma of the skin after cardiac transplantation: a clinical case |
(Rus)
|
|
Ognerubov N.A., Ognerubova M.A.
|
| Vol 10, No 3 (2008) |
Sravnenie effektivnosti i toksichnosti rezhimov FC i FCR u pervichnykh bol'nykhV-kletochnym khronicheskim limfoleykozom |
|
|
Stadnik E.A., Nikitin E.A., Biderman B.V., Salogub G.N., Lorie Y.Y., Tsyba N.N., Alekseeva Y.A., Doronin V.A., Mashchuk V.N., Vabishchevich R.I., Melikyan A.L., Kolosheynova T.I., Kolosova L.Y., Sudarikov A.B., Kovaleva L.G., Zaritskiy A.Y.
|
| Vol 9, No 4 (2007) |
Sravnenie original'nogo preparata filgrastima Neypogen s rossiyskim vosproizvedennym preparatom Leykostim dlya profilaktiki i lecheniya neytropenii na fone polikhimioterapii bol'nykh s prodvinutymi stadiyami limfomy Khodzhkina: analiz «zatraty effektivnost'» i «minimizatsiya zatrat» |
|
|
Tolkushin A.G., Kulikov A.Y., Yagudina R.I., Moiseeva T.N.
|
| Vol 6, No 1 (2004) |
Sravnitel'naya kharakteristika effektivnosti skhem CHOP i Mabtera + CHOP (R-CHOP) v lechenii bol'nykh diffuznoy krupnokletochnoy V-kletochnoy nekhodzhkinskoy limfomoy |
|
|
Poddubnaya I.V., Osmanov D.S., Babicheva L.G., Falaleeva N.A., Borodkina A.G., Unukova E.N.
|
| Vol 7, No 3 (2005) |
Sravnitel'naya kharakteristika taksanosoderzhashchikh i platinovykh skhem polikhimioterapii v pervoy linii lecheniya raka yaichnikov IV stadii (opyt GVKB im. N.N.Burdenko) |
|
|
Mel'ko A.I., Ushakov I.I., Kira E.F., Ermolinskiy I.I.
|
| Vol 11, No 2 (2009) |
Sravnitel'noe issledovanie opredeleniya HER2-statusa raka molochnoy zhelezy metodami immunogistokhimii i in situ gibridizatsii |
|
|
Zavalishina L.E., Andreeva Y.Y., Ryazantseva A.A., Bateva M.V., Frank G.A.
|
| Vol 9, No 2 (2007) |
Sravnitel'noe issledovanie opredeleniya NER2-statusa raka molochnoy zhelezy metodami immunogistokhimii i in situ gibridizatsii |
|
|
Zavalishina L.E., Andreeva Y.Y., Ryazantseva A.A., Bateva M.V., Frank G.A.
|
| Vol 14, No 1 (2012) |
Sravnitel'nyy analiz effektivnosti,bezopasnosti i stoimosti primeneniyarezhimov pemetreksed/tsisplatin,bevatsizumab/gemtsitabin/tsisplatini gemtsitabin/tsisplatin v terapiineploskokletochnogo nemelkokletochnogoraka legkogo pozdnikh stadiy |
|
|
Baraklou K., Orlando M., Orlov S., Rayan N., Deyvi P., Kanivets Y., Khan B., Brnabik A.
|
| Vol 6, No 1 (2004) |
Sravnitel'nyy analiz rezul'tatov obsledovaniya bol'nykh rakom molochnoy zhelezy po dannym rentgenomammograficheskogo i radiotermometricheskogo obsledovaniy |
|
|
Burdina L.M., Pinkhosevich E.G., Khaylenko V.A., Burdina I.I., Vesnin S.G., Tikhomirova N.N.
|
| Vol 21, No 1 (2019) |
Staging and identification of risk groups in pediatric germ cell ovarian tumors |
(Rus)
|
|
Nechushkina I.V., Nechushkina V.M., Boychenko E.I., Susuleva N.A., Kazantsev A.P., Kerimov P.A., Nechushkin M.I., Rubansky M.A.
|
| Vol 18, No 5 (2016) |
State and problems of clinical trials in Russian Federation |
|
|
Kuzmin A.A.
|
| Vol 17, No 2 (2015) |
Stereotactic biopsy of breast lesions under x-ray control |
|
|
Manikhas G.M., Safronova O.B., Khudjakova T.G., Barabanova L.P., Punanova N.J.
|
| Vol 23, No 1 (2021) |
Stomach cancer. Clinical significance of the expression of key components of PD-1/PD-L1 immune checkpoint |
(Rus)
|
|
Kovaleva O.V., Podlesnaya P.A., Gratchev A.N., Chang V.L., Ognerubov N.A., Kushlinskii N.E.
|
| Vol 3, No 3 (2001) |
Storozhevye limfouzly: ikh poisk i znachenie pri rake molochnoy zhelezy |
|
|
Vel'sher L.Z., Gabuniya Z.R., Prazdnikov E.N., Gvakhariya N.V., Luchshev A.I., Ovcharov S.E., Prilepo Y.V.
|
| Vol 8, No 1 (2006) |
Subpopulyatsii transplantiruemykh stvolovykh krovetvornykh kletok |
|
|
Grivtsova L.Y., Tupitsyn N.N.
|
| Vol 21, No 2 (2019) |
Successful experience of combined immunochemotherapy at refractory course of primary cutaneous peripheral T-cell lymphoma, unspecified |
(Rus)
|
|
Gorenkova L.G., Kravchenko S.K., Belousova I.E., Babicheva L.G., Kalashnikova D.D., Poddubnaya I.V.
|
| Vol 16, No 2 (2014) |
Successful treatment with sorafenib in patients with advanced hepatocellular carcinoma: clinical case |
|
|
Bisovskaya Y.V., Breder V.V., Medvedeva B.M., Gorbunova V.A.
|
| Vol 18, No 2 (2016) |
Supportive therapy for ovarian cancer |
(Rus)
|
|
Pokataev I.A., Tyulyandin S.A.
|
| Vol 20, No 2 (2018) |
Surgery for early-stage ovarian cancer |
(Rus)
|
|
Nechushkina V.M., Morkhov K.Y., Abduragimova Z.T., Kuznetsov V.V., Selchuk V.Y., Dmitriev V.N.
|
| Vol 16, No 4 (2014) |
Surgical results in patients 75 years and older with gastric cancer |
|
|
Rokhoev G.A., Stilidi I.S., Nered S.N.
|
| Vol 15, No 2 (2013) |
Surgical stading local – cervical cancer incidence |
|
|
Kargopolova M.V., Maximov S.Y., Berlev I.V., Boyarkina M.P., Meshkova I.E., Khadzhimba A.S., Novikov S.N., Krzhivitsky P.I., Ponomareva O.I., Urmancheeva A.F., Ivanzov A.O., Guseynov K.D., Vishinskaya E.A., Matveeva N.S.
|
| Vol 18, No 4 (2016) |
Surgical treatment and clinicopathological characteristics of patients with neuroendocrine neoplasms of the stomach |
|
|
Bokhyan V.Y., Peregorodiev I.N., Delektorskaya V.V., Arkhiri P.P., Stilidi I.S.
|
| Vol 22, No 4 (2020) |
Surgical treatment for pelvic bone metastases |
(Rus)
|
|
Buharov A.V., Derzhavin V.A., Erin D.A., Yadrina A.V., Aliev M.D.
|
| Vol 23, No 4 (2021) |
Surgical treatment of recurrent ovarian cancer: A review |
(Rus)
|
|
Egenov O.A., Stilidi I.S., Tyulyandina A.S.
|
| Vol 22, No 1 (2020) |
Surgical treatment of trophoblastic disease. Modern concept and contradictions (literature review) |
(Rus)
|
|
Maslennikov A.F., Meshcheriakova L.A., Kuznetsov V.V., Kozachenko V.P., Komarov I.G.
|
| Vol 9, No 3 (2007) |
Sutent® (Sutent, SU11248) – novyy mul'titargetnyy ingibitor angiogeneza opukholey |
|
|
Imyanitov E.N.
|
| Vol 23, No 2 (2021) |
Synchronous thyroid gland metastases from breast cancer. Case reports |
(Rus)
|
|
Ognerubov N.A., Antipova T.S., Palkina E.E.
|
| Vol 18, No 1 (2016) |
Systemic drug therapy of metastatic pancreatic cancer |
(Rus)
|
|
Pokataev I.A., Tyulyandin S.A.
|
| Vol 23, No 1 (2021) |
Systemic treatments for metastatic cutaneous melanoma (Russian Translation of Cochrane Plain Language Summary – PLS) |
(Rus)
|
|
Ziganshin A.U.
|
| Vol 3, No 3 (2001) |
Taksonomicheskaya struktura vozbuditeley infektsiy v onkologicheskoy klinike |
|
|
Dmitrieva N.V., Smolyanskaya A.Z., Petukhova I.N., Sokolova E.N., Sokolova V.I., Kulaga E.V., Bagirova N.S.
|
| Vol 4, No 4 (2002) |
Taksony v optimal'noy khimioterapii raka yaichnikov |
|
|
Urmancheeva A.F.
|
| Vol 4, No 3 (2002) |
Taksoter pri lechenii rasprostranennogo raka yaichnikov |
|
|
Kharitonova T.V.
|
| Vol 8, No 3 (2006) |
Takticheskie podkhody k lecheniyu regionarnykh metastazov u bol'nykh rakom gortani, gortanoglotki, slizistoy obolochki polosti rta i rotoglotki |
|
|
Aydarbekova A., Lyubaev V.L., Tkachev S.I., Alieva S.B., Brzhezovskiy Z.
|
| Vol 11, No 3 (2009) |
Taktika vedeniya bol'nogo metastaticheskim kolorektal'nym rakom s izolirovannymi metastazami v pechen' |
|
|
Tryakin A.A.
|
| Vol 25, No 1 (2023) |
Targeted therapy and hematopoietic stem cell transplantation for relapsed/refractory Hodgkin lymphoma in pediatric and adolescent patients: a pilot protocol results |
(Rus)
|
|
Tsaplina N.S., Valiev T.T., Kirgizov K.I., Varfolomeeva S.R.
|
| Vol 16, No 3 (2014) |
Targeted therapy for metastatic renal cell carcinoma |
|
|
Porta C., Tsimafeyev I.V.
|
| Vol 19, No 2 (2017) |
Targeted therapy in pediatric malignancies treatment: Pediatric Oncology and Haematology Research Institute experience |
(Rus)
|
|
Valiev T.T., Levashov A.S., Batmanova N.A., Senzhapova E.R., Turupaev K.A., Tomchik U.V., Aleskerova G.A.
|
| Vol 23, No 4 (2021) |
Targeted therapy of brain metastases in patients with ALK-positive non-small cell lung cancer: A review |
(Rus)
|
|
Sakaeva D.D., Bulavina I.S.
|
| Vol 15, No 3 (2013) |
Targetnaya terapiya metastaticheskogo raka zheludka: klinicheskiy opyt uspeshnogo lecheniya patsienta s retsidivom raka zheludka |
|
|
Tlish E.K.
|
| Vol 9, No 3 (2007) |
Targetnaya terapiya raka pochki |
|
|
Alekseev B.Y., Shegay P.V.
|
| Vol 11, No 3 (2009) |
Targetnaya terapiya rasprostranennogo raka pochki: problema vybora preparata na primere mul'tikinaznykh ingibitorov |
|
|
Matveev V.B.
|
| Vol 12, No 1 (2010) |
Targetnye preparaty: ratsional'nyyvybor pervoy linii lekarstvennoyterapii disseminirovannogokolorektal'nogo raka |
|
|
Besova N.S.
|
| Vol 14, No 1 (2012) |
Targetnye preparatyi luchevaya terapiya v lecheniimestnorasprostranennogo raka legkogo |
|
|
Ragulin Y.A.
|
| Vol 11, No 4 (2009) |
Tartseva (erlotinib) v terapii rasprostranennoy adenokartsinomy legkogo pri nalichii mutatsii retseptora epidermal'nogo faktora rosta |
|
|
Orlov S.V., Dvorakovskaya I.V., Mosin I.V., Stel'makh L.V., Gorokhov A.A., Martynenko O.N., Poltoratskiy A.N.
|
| Vol 13, No 3 (2011) |
Tasigna odobrena v Rossiidlya lecheniya vzroslykh patsientovs vpervye vyyavlennym khronicheskimmieloidnym leykozom (KhML) |
|
|
- -.
|
| Vol 20, No 1 (2018) |
Taxanes induced peripheral neuropathy: mechanism of development and pharmacogenetic factors |
(Rus)
|
|
Shestakova L.V., Sychev D.A., Poddubnaya I.V.
|
| Vol 10, No 1 (2008) |
Tayverb/Tyverb (lapatinib) – pervyy dvoynoy anti-ErbB1(EGFR)i anti-ErbB2(HER2)-ingibitor v lechenii mestno-rasprostranennogo i metastaticheskogo raka molochnoy zhelezy zaregistrirovan v Rossiyskoy Federatsii |
|
|
- -.
|
| Vol 12, No 3 (2010) |
Tekhnicheskie vozmozhnosti primeneniyakleevoy substantsii pri khirurgicheskikhvmeshatel'stvakh na organakh bryushnoypolosti |
|
|
Gorskiy V.A., Agapov M.A.
|
| Vol 9, No 2 (2007) |
Telekonferentsiya po probleme raka molochnoy zhelezy Moskva, 21 fevralya 2007 g |
|
|
- -.
|
| Vol 23, No 3 (2021) |
Telephone interventions for symptom management in adults with cancer (Russian Translation of Cochrane Plain Language Summary – PLS) |
(Rus)
|
|
Lapshina D.A.
|
| Vol 15, No 1 (2013) |
Tendentsii v diagnostike i lechenii zlokachestvennykh gliom (Po materialam Kongressa «Trends in Central Nervous System Malignancies» pri podderzhke EORTC, ESMO, EANO. Praga, 22–23 marta 2013 g.) |
|
|
Absalyamova O.V.
|
| Vol 12, No 2 (2010) |
Terapevticheskie problemypri limfome zony mantii |
|
|
Poddubnaya I.V.
|
| Vol 13, No 2 (2011) |
Terapiya erlotinibom v sochetaniis gemtsitabinom pri rasprostranennomi/ili metastaticheskom rakepodzheludochnoy zhelezy |
|
|
Voznyy E.K., Popov A.Y., Galkin M.M., Astrakhankina T.A., Ovsyannikov A.A., Polivanov G.E.
|
| Vol 17, No 4 (2015) |
The ability to combine autodermoplasty in the treatment of patients with malignant tumors of the skin extremities (clinical observation) |
|
|
Vaschenko L.N., Dashkova I.R., Kechedzhieva E.E., Babieva S.M.
|
| Vol 24, No 3 (2022) |
The analysis of the relationship between transferrin receptor 1 (TfR1) and clinical, morphological and immunophenotypic characteristics of breast cancer: retrospective cohort study |
(Rus)
|
|
Chulkova S.V., Sholokhova E.N., Poddubnaya I.V., Stilidi I.S., Tupitsyn N.N.
|
| Vol 19, No 2 (2017) |
The application of oral transmucosal fentanyl for the treatment of breakthrough pain in cancer patients |
(Rus)
|
|
Nevzorova D.V., Kunyaeva T.A., Ibragimov A.N.
|
| Vol 16, No 1 (2014) |
The Avastin application in clinical practice in patients with metastatic colorectal cancer: Second interim analysis of the observational AJAX program |
|
|
Poddubnaya I.V., Bichurina S.A., Bobrovskaya E.V., Vladimirova L.Y., Gordeev S.S., Davidenko I.S., Emelyanov S.A., Zharkova O.V., Koroleva I.A., Krasilnikova S.Y., Maikoparova S.C., Malysheva T.A., Modestov A.A., Morozov A.N., Petrukhnenko V.A., Sivunova I.D., Stachenko G.B., Strygina E.A., Tlish E.K., Feoktistova P.S., Chichkanova A.S., Sherman N.Z.
|
| Vol 16, No 2 (2014) |
The beginning of the new era of monoclonal antibodies biosimilars use in oncology:current international guidelines and the results of clinical trial of the first Russian rituximab biosimilar in patients with B-cell non-Hodgkin’s lymphoma |
|
|
Kaplanov K.D., Zaritskey A.Y., Alekseev S.M., Ivanov R.A., Chernyaeva E.V.
|
| Vol 24, No 1 (2022) |
The biobank of the National Medical Research Centre for Oncology as a resource for research in the field of personalized medicine: A review |
(Rus)
|
|
Kit O.I., Timofeeva S.V., Sitkovskaya A.O., Novikova I.A., Kolesnikov E.N.
|
| Vol 19, No 1 (2017) |
The characteristics of determination of BRCA1 and BRCA2 mutations in serous ovarian cancer |
(Rus)
|
|
Demidova I.A.
|
| Vol 19, No 1 (2017) |
The choice of treatment method in patients with complicated gastrointestinal stromal tumors. Clinical observation and literature review |
(Rus)
|
|
Nered S.N., Stilidi I.S., Shalenkov V.A., Arkhiri P.P., Perfilev I.B., Kalinin A.E., Bozhchenko Y.A., Glukhov E.V.
|
| Vol 18, No 5 (2016) |
The clinical relevance of flow cytofluorometry in the diagnosis of malignant non-Hodgkins lymphoma |
|
|
Fominyh T.L., Simonova N.A.
|
| Vol 26, No 3 (2024) |
The combination of lenvatinib and pembrolizumab in the treatment of patients with metastatic kidney cancer and factors of poor prognosis: experience of clinics in Moscow: A prospective observational study |
(Rus)
|
|
Pokataev I.A., Stroyakovskiy D.L., Fedyanin M.Y., Zhukova L.G., Stativko O.A., Andreyashkina I.I., Volkova M.I., Volkonskiy M.V., Polshina N.I., Kotova E.V., Kravchuk D.A., Bystrov A.A., Antonova T.G., Lyadova M.A., Kuzmina E.S., Parts S.A., Salpagarov M.K., Galkin V.N., Klimov A.V.
|
| Vol 19, No 1 (2017) |
The comparative pharmacoeconomic analysis of tyrosine kinase inhibitor Iressa® (gefitinib) with TKI Giotrif® (afatinib) as first-line therapy for patients with advanced non-small cell lung cancer associated with mutations in the epidermal growth factor receptor |
(Rus)
|
|
Ryazhenov V.V.
|
| Vol 15, No 2 (2013) |
The concept of resectability in the treatment of colorectal cancer liver metastases: the present notion |
|
|
Bagmet N.N., Bedzhanyan A.L., Polishchuk L.O., Sekacheva M.I., Shatveryan G.A., Skipenko O.G.
|
| Vol 22, No 4 (2020) |
The consensus on the prevention and correction of hyperglycemia in patients with HR+ HER2- metastatic breast cancer treated with alpelisib |
(Rus)
|
|
Mazurina N.V., Artamonova E.V., Beloyartseva M.F., Volkova E.I., Ganshina I.P., Troshina E.A., Tjulandin S.A., Chubenko V.A.
|
| Vol 23, No 4 (2021) |
The consensus on the prevention and correction of rash in patients with HR+ HER2- metastatic breast cancer treated with alpelisib |
(Rus)
|
|
Shlivko I.L., Garanina O.E., Artamonova E.V., Ganshina I.P., Zhukova L.G., Koroleva I.A., Michenko A.V., Semiglazova T.Y., Filonenko D.A.
|
| Vol 21, No 2 (2019) |
The cost-effectiveness of treatment of relapsed/refractory chronic lymphocytic leukemia with a combination of venetoclax and rituximab |
(Rus)
|
|
Rudakova A.V., Strugov V.V.
|
| Vol 24, No 2 (2022) |
The effect of antioxidant drugs on the self-assessment of clinical symptoms in women during radiation therapy after surgical treatment of endometrial cancer: Placebo-controlled randomized trial |
(Rus)
|
|
Volchegorskii I.A., Vazhenin A.V., Alekseeva A.P.
|
| Vol 25, No 1 (2023) |
The effect of CDK4/6 inhibitors on the overall survival in patients with advanced HR+/HER2- BC in the entire population and in special clinical subgroups of unfavorable prognosis: A review |
(Rus)
|
|
Grechukhina K.S., Kalugin M.V., Prosvirnov A.A., Sukhova M.V., Zhukova L.G.
|
| Vol 16, No 4 (2014) |
The effect of combinated treatment of a metastatic HER2-positive stomach cancer |
|
|
Khvastunov R.A., Nenarokomov A.Y., Tolstopiatov S.E., Babina K.G.
|
| Vol 20, No 1 (2018) |
The effect of derivatives of 3-hydroxypyridine and succinic acids on depressive symptoms, pain intensity and quality of life after surgical treatment of breast cancer |
(Rus)
|
|
Volchegorskii I.A., Vazhenin A.V., Zyuzina M.S.
|
| Vol 25, No 2 (2023) |
The effect of hormonal contraception on the risk of breast cancer: A review |
(Rus)
|
|
Iurova M.V., Mezhevitinova E.A., Yakushevskaya O.V., Rodionov V.V., Prilepskaya V.N.
|
| Vol 22, No 1 (2020) |
The effect of local immunity on gastric cancer prognosis |
(Rus)
|
|
Khakimova G.G., Tryakin A.A., Zabotina T.N., Borunova A.A., Malikhova O.A., Juraev F.M., Peregorodiev I.N., Zaharova E.N., Tabakov D.V.
|
| Vol 20, No 4 (2018) |
The effectiveness of targeted therapy in the treatment of common forms of ovarian cancer |
(Rus)
|
|
Saevets V.V., Vazhenin A.V., Chernova L.F., Shimotkina I.G., Kurchenkova O.V., Mukhin A.A., Taratonov A.V.
|
| 1101 - 1200 of 1398 Items |
<< < 1 2 3 4 5 6 7 8 9 10 11 12 13 14 > >> |
